AfricaCongo declares end of Ebola outbreak that killed six
Reuters
1/4
Thermometers are pictured at the entrance of an Ebola Treatment Centre in the Eastern Congolese town of Butembo in the Democratic Republic of Congo, October 4, 2019. REUTERS/Zohra Bensemra
Read More
The Democratic Republic of Congo on Monday declared the end of an Ebola outbreak that infected 12 people in the eastern province of North Kivu and killed six of them.
The outbreak was contained using Merck s (MRK.N) Ebola vaccine, which was given to more than 1,600 of the patients contacts and contacts of contacts, the aid group Medecins Sans Frontieres (MSF), said.
Healthcare & PharmaceuticalsPanama orders men and women to shop on different days to curb coronavirus
Reuters
1 minute read
Panama will next week reimpose nationwide curbs on movement by requiring men and women to carry out festive shopping on different days, the health minister said on Friday, imposing drastic measures following a surge in coronavirus cases.
The restrictions are similar to what the Central American nation imposed in worst-hit parts of the country in June. As of Monday 21, with the aim of reducing mobility, purchases will be made by gender, Luis Sucre, the Minister of Health, said in a televised message.
On Christmas and New Year s Day there will be total quarantine for both genders.
EuropeGermany s confirmed coronavirus cases rise by 23,392 - RKI
Reuters
1 minute read
General view of shopping boulevard Neuer Wall during a lockdown, amid the coronavirus disease (COVID-19) pandemic in Hamburg, Germany April 23, 2021. Picture taken April 23, 2021. REUTERS/Fabian Bimmer
The number of confirmed coronavirus cases in Germany increased by 23,392 to 3,268,645, data from the Robert Koch Institute (RKI) for infectious diseases showed on Saturday. The reported death toll rose by 286 to 81,444, the tally showed.
WASHINGTON (Reuters) - Johnson & Johnson's COVID-19 vaccine remained in limbo on Wednesday evening as a U.S. health panel called for more data before making a decision on how and whether to resume use of the one-dose shot, putting off a vote for a week or more.
United StatesJ&J COVID-19 vaccine pause to be reviewed by U.S. panel next week
Carl O donnellManas Mishra
2 minutes read
Johnson & Johnson s coronavirus disease (COVID-19) vaccines are seen at Northwell Health s South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton
(Reuters) - A U.S. panel will meet again next week to discuss whether the pause on the use of Johnson & Johnson s COVID-19 vaccine should continue, after delaying a vote on the matter earlier this week.
The U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on April 23, a top U.S. health official said on Friday.